[Ca-antagonist, K-channel-opener in the treatment of patients with congestive heart failure].
The development of vasodilator drugs that open the K+ channels in blood vessels has been of great academic and practical interest. The K-channel openers (cromakalim, pinacidil and nicorandil) decreased afterload or preload due to their vasodilator action. In addition, K-channel openers produced a cardioprotective effect in lower doses that did not affect coronary blood flow or blood pressure. It is highly expected to be useful for treatment of congestive heart failure.